Keryx Biopharmaceuticals Announces $125 Million Private Placement of Convertible Senior Notes With The Baupost Group, L.L.C.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
FBR Capital Reiterates Market Perform Following Keryx Biopharma's (KERX) Recent Financing
October 19, 2015 2:48 PM EDTFBR Capital reiterated a Market Perform rating and $10.00 price target on Keryx Biopharmaceuticals (NASDAQ: KERX) following recent financing. Keryx Biopharmaceuticals raised $125 million in a private placement exchange of senior convertible notes with the Baupost Group.
Analyst Christopher James commented, "Last week, Keryx Biopharmaceuticals raised $125 million in a private... More
Keryx Biopharma (KERX) Announces $125M Private Placement of Conv. Notes with The Baupost Group
October 15, 2015 7:02 AM EDTKeryx Biopharma (NASDAQ: KERX) announced that it has entered into an agreement to raise $125 million through the private placement of Convertible Senior Notes, due 2020, with funds managed by The Baupost Group, L.L.C. With the additional capital, Keryx has a pro-forma cash position of approximately $225 million as of September 30, 2015. In conjunction with the financing, Keryx will increase the number of directors on its Board to eight, as Baupost will have the right to appoint a director to Keryxs Board by the end of 2015. Baupost will also appoint an observer to Keryxs... More
